Taking everything into account, ENOB scores 2 out of 10 in our technical rating. Recently some decent action could be observed, but in the medium term time frame this is still negative. ENOB was also a bad performer in the overall market in the last year.
97% of all other stocks performed better in the past year than ENOB.
ENOB is part of the Biotechnology industry. There are 568 other stocks in this industry, of which 82% are performing better than ENOB.
ENOB is currently trading in the lower part of its 52 week range, which is not a good signal. Agreed, the S&P500 Index is also not doing fantastic, but it still sitting in the middle of its 52 week range.
Considerably lower volume is observed in the last couple of days, which is not what you would like to see during a strong up movement.
In the last month ENOB has a been trading in the 0.46 - 0.76 range, which is quite wide. It is currently trading near the high of this range.
The short term trend is positive, while the long term trend is still negative. So this is evolving in the right direction, but it may need some more time to really turn around the trend.
Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.